Mitsubishi Chemical Corp. is moving to accelerate its M&A strategies in the area of performance products. With an investment and…...
Please subscribe to read the full story.
NeuroDerm
Mitsubishi Tanabe to Acquire Israeli-Based NeuroDerm for $1.1 Billion
Mitsubishi Tanabe Pharma Corp. (TYO:4508) announced an agreement on July 24 to acquire Israeli-based NeuroDerm Ltd. for about $1.1 billion,…...
Please subscribe to read the full story.
